BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:195@biocityturku.fi
DTSTART;TZID=Europe/Helsinki:20190115T130000
DTEND;TZID=Europe/Helsinki:20190115T160000
DTSTAMP:20231013T060903Z
URL:https://biocityturku.fi/events/translating-molecules-to-treatments-i/
SUMMARY:TRANSLATING MOLECULES TO TREATMENTS I
DESCRIPTION:DRUG DEVELOPMENT AND DIAGNOSTICS MINI-SYMPOSIUM\nTRANSLATING MO
 LECULES TO TREATMENTS I\n13.00-13.10 Opening words by Associate Professor 
 Diana Toivola\n13.10-14.00 M. Bishr Omary Molecular Pathogenesis of Porphy
 ria and Therapeutic Approaches Using Zebrafish Models\nM. Bishr Omary is P
 rofessor of Molecular &amp\; Integrative Physiology\, the H Marvin Pollard
  Professor of Gastroenterology\, Professor of Internal Medicine\, and Spec
 ial Advisor on Research to the Dean at University of Michigan in Ann Arbor
 \, USA. He is also guest professor in Drug Development and Diagnostics at 
 Åbo Akademi University in Turku. Bishr is a world leader in the area of i
 ntermediate filamentsand their associated diseases\, with special focus on
  the regulation and function of keratins and lamins in digestive organs. A
 nother active area of research in his laboratory involves studying the mec
 hanism of porphyrin mediated cell damage in the context of the genetic por
 phyria disorders. He currently utilizes high throughput drug screening app
 roaches to identify compounds with potential therapeutic benefits for inte
 rmediate filament associated diseases and for porphyrias.\nhttps://medicin
 e.umich.edu/dept/molecular-integrative-physiology/bishr-omary-md-phd\n14:0
 0-14.50 Caroline Heckman Personalizing Patient Care to Overcome Drug Resis
 tance in Hematological Malignancies\nCaroline Heckman is a Group leader an
 d Principal Investigator at the Institute for Molecular Medicine Finland F
 IMM\, Helsinki Institute of Life Sciences\, University of Helsinki in Finl
 and. Caroline’s research is focused on understanding the mechanisms driv
 ing disease progression and drug resistance in hematological malignancies.
  She also applies technologies for better translation of basic research re
 sults towards clinical implementation.\nhttps://www.fimm.fi/en/research/gr
 oups/heckman\n14.50-15.10 Coffee break\n15.10-16.00 "The ABCs of a postdoc
  in the US" with M. Bishr Omary\nThis interactive session is open to all i
 nterested and will cover tips and advice on doing a postdoc in general and
  especially related to being a postdoc in US.\nRegister before Friday Janu
 ary 11th at https://survey.abo.fi/lomakkeet/10837/lomake.html\nFor more in
 formation\, contact Diana Toivola\, e-mail: diana.toivola@abo.fi\n\n&nbsp\
 ;
CATEGORIES:BiocityTurku events,Other events
LOCATION:#_LOCATIONNAME\, #_LOCATIONFULLLINE\, #_LOCATIONCOUNTRY
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=#_LOCATIONFULLLINE\, #_LOCA
 TIONCOUNTRY;X-APPLE-RADIUS=100;X-TITLE=#_LOCATIONNAME:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:STANDARD
DTSTART:20181028T030000
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
END:STANDARD
END:VTIMEZONE
END:VCALENDAR